Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Analysis of unregulated sale of life-saving prescription drugs online in the United States

JAMA | Feb 22, 2020 Clinical Pharmacology

Bimekizumab in patients with active psoriatic arthritis: Results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial

The Lancet | Feb 21, 2020 Clinical Pharmacology

A topical cell therapy approach for diabetic chronic ulcers: Effects of mesenchymal stromal cells associated with platelet-rich plasma

Journal of Cosmetic Dermatology | Feb 21, 2020 Clinical Pharmacology

Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome

JAMA | Feb 19, 2020 Clinical Pharmacology

Erlotinib for palmoplantar keratoderma in patients with olmsted syndrome caused by TRPV3 mutations

JAMA | Feb 19, 2020 Clinical Pharmacology

Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: A randomized clinical trial

JAMA | Feb 19, 2020 Clinical Pharmacology

Effect of topical brimonidine on alcohol-induced flushing in Asian individuals: A randomized clinical trial

JAMA | Feb 19, 2020 Clinical Pharmacology

Treatment of childhood-onset lupus erythematosus panniculitis with rituximab

JAMA Dermatology | Feb 19, 2020 Clinical Pharmacology

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: A randomised, placebo-controlled phase II trial

BMJ Open | Feb 18, 2020 Clinical Pharmacology

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis

Journal of the European Academy of Dermatology and Venereology | Feb 14, 2020 Clinical Pharmacology

« Prev 1 … 36 37 38 39 40 … 92 Next »

Analysis of unregulated sale of life-saving prescription drugs online in the United States

Bimekizumab in patients with active psoriatic arthritis: Results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial

A topical cell therapy approach for diabetic chronic ulcers: Effects of mesenchymal stromal cells associated with platelet-rich plasma

Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome

Erlotinib for palmoplantar keratoderma in patients with olmsted syndrome caused by TRPV3 mutations

Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: A randomized clinical trial

Effect of topical brimonidine on alcohol-induced flushing in Asian individuals: A randomized clinical trial

Treatment of childhood-onset lupus erythematosus panniculitis with rituximab

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: A randomised, placebo-controlled phase II trial

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Analysis of unregulated sale of life-saving prescription drugs online in the United States

Bimekizumab in patients with active psoriatic arthritis: Results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial

A topical cell therapy approach for diabetic chronic ulcers: Effects of mesenchymal stromal cells associated with platelet-rich plasma

Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome

Erlotinib for palmoplantar keratoderma in patients with olmsted syndrome caused by TRPV3 mutations

Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: A randomized clinical trial

Effect of topical brimonidine on alcohol-induced flushing in Asian individuals: A randomized clinical trial

Treatment of childhood-onset lupus erythematosus panniculitis with rituximab

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: A randomised, placebo-controlled phase II trial

Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Artice: Adult Vaccination Updates Every Family Doctor Should Know

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic